Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2023 ∙ Ayyalasomayajula, S. Dhawan, A. Karattuthodi, M. S. Thorakkattil, S. A. Abdulsalim, S. Elnaem, M. H. Sridhar, S. Unnikrishnan, M. K.
A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population
Adults Older adults COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Alhandod, T. A. Rabbani, S. I. Almuqbil, M. Alshehri, S. Hussain, S. A. Alomar, N. F. Mir, M. A. Asdaq, S. M. B.
A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia
Eastern Mediterranean Saudi Arabia Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Kumar, G. Jena, S. Snigdha, N. T. Basha, S. Narayanan, J. K. Luke, A. M.
Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis
South-East Asia India All age groups Healthcare workers COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Amisha, F. Saluja, P. Malik, P. Van Rhee, F.
Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Nabizadeh, F. Noori, M. Rahmani, S. Hosseini, H.
Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Liatsou, E. Ntanasis-Stathopoulos, I. Lykos, S. Ntanasis-Stathopoulos, A. Gavriatopoulou, M. Psaltopoulou, T. Sergentanis, T. N. Terpos, E.
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Putri, E. A. C. Munir, M. Setiawan, H. K. Herawati, L. Sari, G. M. Wungu, C. D. K. Susilo, H. Sutanto, H.
Adverse cardiac events following mRNA COVID-19 vaccination: A systematic review and meta-analysis
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Yasmin, F. Najeeb, H. Naeem, U. Moeed, A. Atif, A. R. Asghar, M. S. Nimri, N. Saleem, M. Bandyopadhyay, D. Krittanawong, C. Fadelallah Eljack, M. M. Tahir, M. J. Waqar, F.
Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
All age groups COVID-19 Safety
Rating:
Critically low
2023 ∙ Zhang, H. Q. Cao, B. Z. Cao, Q. T. Hun, M. Cao, L. Zhao, M. Y.
An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Bachour, Y.
An update and overview of the literature on late inflammatory reactions (LIRs) in soft tissue fillers after SARS-CoV-2 infection and vaccination
All age groups COVID-19 Safety
Rating:
Critically low
Loading...